Skip to main navigation Skip to search Skip to main content

TaiGen Biotechology Co. Ltd:A Phase II, Open-Label Study to Evaluate the Hematopoietic Stem Cell Mobilization of TG-0054 Combined with G-CSF with G-CSF in Patients with Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Project: Research

Project Details

StatusFinished
Effective start/end date01/22/1512/5/18

Funding

  • Covance: $192,373.82